CELH
Celsius Holdings, Inc.
CELH has the edge over MZTI overall, supported by stronger fundamentals and stronger modeled upside.
MZTI
The Marzetti Company
MZTI has lower modeled downside risk, despite its lower overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
MZTI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Healthy |
MZTI's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
MZTI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 16x | $111 | — |
| Current | 17x | $111 | — |
| Cheap | 27x | $173 | +56% |
| Fair | 34x | $216 | +95% |
| Expensive | 41x | $262 | +137% |
Historical ranges are pointers, not guarantees.
MZTI has the edge over CELH in the historical PE scenario, which offers more potential upside but is not a forecast.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over MZTI on the outlook, with more favorable earnings and revenue expectations.
MZTI Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Stable | |
| Stable | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect MZTI's earnings, revenue and profitability to hold roughly steady.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
MZTI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.71 | +5.8% |
| Q3 2026 | $6.34 | +2.9% |
| Q2 2026 | $6.98 | +15% |
| Q1 2026 | $6.39 | +3.7% |
| Q4 2025 | $6.53 | +15% |
| Q3 2025 | $6.16 | +6.4% |
| Q2 2025 | $6.07 | +5.4% |
| Q1 2025 | $6.16 | +28% |
| Q4 2024 | $5.70 | +22% |
MZTI has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over MZTI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over MZTI on profitability, with a higher operating margin.
MZTI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $481.5M | -2.4% |
| Q2 2026 | $465M | -2.2% |
| Q1 2026 | $453.4M | -1% |
| Q4 2025 | $518M | +1.7% |
| Q3 2025 | $493.5M | +5.8% |
| Q2 2025 | $475.4M | +5% |
| Q1 2025 | $457.8M | -2.9% |
| Q4 2024 | $509.3M | +4.8% |
MZTI's revenue grew through 2023 and has held roughly level since: $482M last quarter, down 2.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.6% | -3.4 points |
| Q2 2026 | 12% | +4.2 points |
| Q1 2026 | 10% | -0.6 points |
| Q4 2025 | 15% | -0.3 points |
| Q3 2025 | 12% | 0 points |
| Q2 2025 | 8.2% | -1 points |
| Q1 2025 | 11% | +3.4 points |
| Q4 2024 | 15% | +1.3 points |
MZTI's operating margin was 8.6% last quarter, down 3.4 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH has the edge over MZTI on cash flow, with stronger typical year-over-year growth.
MZTI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.1M | -39% |
| Q2 2026 | $32.1M | -57% |
| Q1 2026 | $49.3M | +60% |
| Q4 2025 | $70.9M | -27% |
| Q3 2025 | $53.9M | +2287% |
| Q2 2025 | $73.9M | +299% |
| Q1 2025 | $30.8M | -50% |
| Q4 2024 | $96.6M | +11% |
MZTI generated $185M in free cash flow over the past year, down 27% from the year before.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over MZTI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
MZTI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.5% | -131K shares |
| 1 year | -0.8% | -219K shares |
| 3 years | -0.7% | -198K shares |
| 5 years | -0.9% | -240K shares |
| Available history | -0.8% | -214K shares |
MZTI has 27M diluted shares, down 0.8% from a year ago, with $41M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5.8M |
| Q2 2026 | $15.1M |
| Q1 2026 | $16,000 |
| Q4 2025 | $20.1M |
| Q3 2025 | $1.1M |
| Q2 2025 | $6.5M |
| Q1 2025 | $76,000 |
| Q4 2024 | $3,000 |
MZTI spent $41M buying back its own shares over the past year, about five times what it spent the year before.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has the edge over MZTI on leverage, with a lower net debt burden relative to earnings.
MZTI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.6x | Very low |
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | -0.8x | Net Cash |
| Q4 2025 | -0.7x | Net Cash |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.6x | Net Cash |
| Q1 2025 | -0.4x | Net Cash |
| Q4 2024 | -0.8x | Net Cash |
MZTI's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
MZTI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 47.5 | Neutral |
MZTI's weekly RSI is 47 (neutral) and its Stochastic is 48 (neutral).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
MZTI PE vs Consumer Defensive Sector
| Metric | MZTI | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 19x | 11% below |
| PE % | 4 | 18 | 14 pts below |
MZTI has the edge over CELH on valuation relative to its sector.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
MZTI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.8 | 5.5% above |
| 20 week MA | $107.8 | 2.6% above |
| 50 week MA | $129.4 | 15% below |
| 100 week MA | $152.6 | 28% below |
| 200 week MA | $169.6 | 35% below |
MZTI has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 35% below its 200-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH has the edge over MZTI on returns for 2026, with the stronger performance.
MZTI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $160.4 | $174.3 | +8.7% |
| 2021 | $174.3 | $162.2 | -7% |
| 2022 | $162.2 | $200.8 | +24% |
| 2023 | $200.8 | $166.4 | -17% |
| 2024 | $166.4 | $175.9 | +5.7% |
| 2025 | $175.9 | $165.9 | -5.7% |
| 2026 YTD | $165.9 | $110.5 | -33% |
MZTI has finished lower in three of the last six years. It's down 33% so far in 2026.